Locked nucleic acid (LNA) based PCR approach for the diagnosis and screening of spinal muscular atrophy
The Indian Journal of Medical Research · 24.03.2026 · 163 · 194-201
DOI: 10.25259/ijmr_2408_2025 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Indian Journal of Medical Research, online erschienen am 24.03.2026. Verfasst von Gökçe Güllü Amuran und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Biology, School of Medicine, Marmara University, Istanbul, Turkey. Hauptthemen laut MEDLINE: Muscular Atrophy, Spinal, Survival of Motor Neuron 1 Protein, Oligonucleotides, Polymerase Chain Reaction. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background and objectives Spinal muscular atrophy (SMA) is an autosomal recessive disorder most often caused by homozygous deletion of exon 7 in the SMN1 gene. Current guidelines recommend initial testing of SMN1 exon 7, with additional analyses if no deletions are found. Commercial kits are typically probe-based; however, LNA (locked nucleic acid)-modified primers provide high sensitivity and specificity at lower cost. We aimed to develop an LNA-based assay for the diagnosis and screening of SMA.
Methods
Peripheral blood samples (2 mL) were collected from 31 patients diagnosed with SMA, 37 confirmed healthy controls, and 47 carrier parents between September and December 2021. 3′ LNA-modified primers were designed for the SMN1 , SMN2 , and β-actin genes. For each PCR reaction, 20 ng of template DNA was used in a final volume of 20 µL. Products were validated by Sanger sequencing, and ΔCt values were compared with multiplex ligation-dependent probe amplification (MLPA).
Results
The LNA primers for SMN1 , SMN2 , and β-actin were designed and optimised to amplify efficiently under uniform polymerase chain reaction (PCR) conditions. PCR results and ΔCt values were fully concordant with MLPA results. Interpretation and conclusions Using only LNA-modified primers, we accurately detected SMN1 and SMN2 presence, absence, and copy numbers, without probes. This assay reliably identified both SMA patients and carriers, supporting its potential for diagnostic and screening purposes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Biology, School of Medicine, Marmara University, Istanbul, Turkey.
- Institute of Health Sciences, Marmara University, Istanbul, Turkey.
- Department of Pediatric Neurology, School of Medicine, Marmara University, Istanbul, Turkey.
Zitieren
APA
Amuran, G. G., Polat, B., Türkdoğan, D., Ünver, O., & Akkiprik, M. (2026). Locked nucleic acid (LNA) based PCR approach for the diagnosis and screening of spinal muscular atrophy. The Indian Journal of Medical Research, 163, 194-201. https://doi.org/10.25259/ijmr_2408_2025
Vancouver
Amuran GG, Polat B, Türkdoğan D, Ünver O, Akkiprik M. Locked nucleic acid (LNA) based PCR approach for the diagnosis and screening of spinal muscular atrophy. The Indian Journal of Medical Research. 2026;163:194-201. doi:10.25259/ijmr_2408_2025
BibTeX
@article{Amuran2026,
author = {Amuran, Gökçe Güllü and Polat, Büşra and Türkdoğan, Dilşad and Ünver, Olcay and Akkiprik, Mustafa},
title = {Locked nucleic acid (LNA) based PCR approach for the diagnosis and screening of spinal muscular atrophy},
journal = {The Indian Journal of Medical Research},
year = {2026},
volume = {163},
pages = {194--201},
doi = {10.25259/ijmr_2408_2025}
}
EUVIMED